Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Colorectal Neoplasms 3Neoplasms 2Breast Neoplasms 2Ovarian Neoplasms 1Lymphoma, Follicular 1Depression 1Dementia 1Colonic Neoplasms 1COVID-19 1Breast Cancer Screening 1

Interventions

Trastuzumab 243Paclitaxel 193Cyclophosphamide 158Docetaxel 134Letrozole 113Capecitabine 113Fulvestrant 106Doxorubicin 103Bevacizumab 87Carboplatin 81exemestane 80Anastrozole 79Lapatinib 70Tamoxifen 69Albumin-Bound Paclitaxel 57palbociclib 54pertuzumab 53Taxes 51Gemcitabine 50Radiotherapy 46eribulin 43pembrolizumab 41Everolimus 41Ado-Trastuzumab Emtansine 41Vinorelbine 38130-nm albumin-bound paclitaxel 35ixabepilone 32Epirubicin 28pegfilgrastim 25liposomal doxorubicin 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Breast Neoplasms × Decision Support Techniques × Clear all
NCT05376241 2026-03-27

Promoting Informed Choice for Breast Cancer Screening

University of Colorado, Denver

Phase 2 Completed
637 enrolled 10 charts
Breast

Breast Neoplasms

NCT03097653 2021-03-24

Decision-aid on Breast Cancer Screening

Mario Negri Institute for Pharmacological Research

Phase NA Completed
1,001 enrolled 17 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡